Cost minimization analysis of a hexavalent vaccine in Argentina
Abstract Background Argentina currently uses a pentavalent vaccine containing diphtheria, tetanus, pertussis (whole cell), Haemophilus influenza type b and hepatitis B antigens, administered concomitantly with the inactivated polio vaccine (IPV) (DTwP-Hib-HB plus IPV) in its childhood vaccination sc...
Main Authors: | Ignacio Olivera, Carlos Grau Pérez, Luis Lazarov, Eduardo Lopez, Cristian Oddo, Hugo Dibarboure |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-10-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-023-10038-0 |
Similar Items
-
Decline of serologic immunity to diphtheria, tetanus and pertussis with age suggested a full life vaccination in mainland China
by: Dandan Liu, et al.
Published: (2021-06-01) -
Seroepidemiology of pertussis and diphtheria among healthy adults in Shaanxi Province, northwest China: A large - scale cross-sectional study
by: Chao Zhang, et al.
Published: (2022-11-01) -
Safety and immunogenicity of an indigenously developed tetanus toxoid, diphtheria toxoid, and acellular pertussis vaccine (Tdap) in adults, adolescents, and children in India
by: Hitt J Sharma, et al.
Published: (2023-12-01) -
DTaP5-IPV-Hib-HepB, a hexavalent vaccine for infants and toddlers
by: Andrew W. Lee, et al.
Published: (2017-02-01) -
Seroprevalence of Antibodies against Diphtheria, Tetanus and Pertussis in Adult At-Risk Patients
by: Lise Boey, et al.
Published: (2021-01-01)